Zurueck zur Suche

Reporte zur Charge U039721

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

5Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
PA 2 TX 1 WI 1

VAERS 2248238

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u039721

moderat
Staat
TX
Alter
41,0
Geschlecht
F
Eingang
22.04.2022
Impfdatum
19.04.2022
Beginn
20.04.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Chest pain Dyspnoea

Symptomtext

Patient informed of receiving a Pneumoccocal vaccine (PPSV23) who is allergic to Diphtheria Toxoid/Pertussis Vaccine/Tetanus Toxoid on 4/19/2022. Pt indicated receiving Covid Booster Vaccination on 4/19/2022 as well. Patient with ER visit on 4/20/2022 d/t chest pain and SOB.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
1. Seasonal allergic rhinitis 2. Renal tubular acidosis 3. Epilepsy 4. Pulmonary embolism 5. Migraine 6. Chronic hypoxemic respiratory failure 7. Obstructive sleep apnea of adult 8. Brachial plexus neuropathy 9. Menorrhagia 10. Raynaud phenomenon 11. Leucopenia 12. Lumbosacral radiculopathy 13. Common blue nevus of skin 14. Melanocytic nevus
Andere Medikamente
Unknown
Allergien
CLARITHROMYCIN, AMITRIPTYLINE DIPHTHERIA TOXOID/PERTUSSIS VACCINE/TETANUS TOXOID
Vorherige Impfungen
-

VAERS 2525215

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U039721

mild
Staat
-
Alter
68,0
Geschlecht
M
Eingang
07.12.2022
Impfdatum
22.09.2022
Beginn
23.09.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dizziness Headache Injection site pain Injection site swelling

Symptomtext

Narrative: 68 year old MALE c/o severe headache, dizziness and injection site pain and swelling after her received 3 shots yesterday for flu, covid bivalent booster and pneumonia. No fever. He has been applying warm compresses to injection site. Pain has reduced now, headache resolved after he rested for 45 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2678056

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U039721

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
31.08.2023
Impfdatum
18.08.2023
Beginn
18.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

has not experienced any adverse effects; inadvertently administered after its labeled expiry date; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 18-AUG-2023, the patient was inadvertently vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 1 dose, administered for prophylaxis (lot# U039721, expiration date: 10-AUG-2023; strength and route of administration were not provided) after its labeled expiry date (expired product administered). The patient had not experienced any adverse effects. The health care professional confirmed there was no temperature excursion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2603869

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U039721

gering
Staat
PA
Alter
-
Geschlecht
F
Eingang
27.03.2023
Impfdatum
21.03.2023
Beginn
01.03.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Incorrect route of product administration Vaccination site erythema

Symptomtext

dose of PNEUMOVAX 23 was administered intradermally by a medical assistant; red raised area "the size of her pinky"; red line running down her arm, to her; This spontaneous report has been received from a nurse referring to a 66-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 21-MAR-2023, the patient started therapy with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 0.5 ml, (lot #U039721 had been verified to be a valid number; expiration date 10-AUG-2023, and upon internal validation established as the same date) administered intradermally for prophylaxis (strength was not provided) (Incorrect route of product administration). On an unspecified date in March 2023, the patient experienced a red raised area "the size of her pinky" (vaccination site erythema) and a faint red line running down her arm, to her deltoid (erythema). The outcome of the events was not provided. The causal relationship between the events of vaccination site erythema and erythema, with the vaccine pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2439310

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U039721

gering
Staat
WI
Alter
-
Geschlecht
F
Eingang
10.09.2022
Impfdatum
09.08.2022
Beginn
09.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse events; PNEUMOVAX 23 that experienced a temperature excursion was administered to 1 patient; This spontaneous report was received from a medical student and refers to a 88-year-old female patient. No information regarding patient's pertinent medical history, drug reactions, allergies and concomitant medications was reported. On 09-AUG-2022, the patient was vaccinated with improperly stored pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, vial, at a dose of 0.5 ml, lot # U039721, expiration date 10-AUG-2023 for prophylaxis (dose #, anatomical location and route of administration were not provided). The vaccine experienced a temperature excursion of 32.7 Fahrenheit (F) for 24 hours minutes (product storage error). There was no previous temperature excursion. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-